Entera Bio Ltd. ENTX
NASDAQ · United States · Health Technology
$2.89-0.02 (-0.69%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-07 | -0.14 | -0.08 | -75.0% | $0 | — | +7.8%$2.82→$3.04 |
| Q1 2026 | 2026-05-08 | -0.07 | -0.08 | +12.5% | — | — | -14.6%$1.37→$1.17 |
| Q4 2025 | 2026-03-27 | -0.06 | -0.09 | +33.3% | — | — | -2.9%$1.03→$1.00 |
| Q3 2025 | 2025-11-14 | -0.07 | -0.09 | +22.2% | — | — | -2.2%$2.74→$2.68 |
| Q2 2025 | 2025-08-08 | -0.06 | -0.11 | +45.5% | — | — | — |
| Q1 2025 | 2025-05-09 | -0.06 | -0.07 | +14.3% | — | — | — |
| Q4 2024 | 2025-03-28 | -0.06 | -0.08 | +25.0% | — | — | — |
| Q3 2024 | 2024-11-08 | -0.08 | -0.05 | -60.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.